The MiniMed Paradigm real-time insulin pump and continuous glucose monitoring system is a therapy available for patients who use insulin to treat diabetes. The pump integrates with real-time continuous glucose monitoring (CGM). This new technology will help patients take immediate corrective or preventive action to maintain healthy glucose levels and delay or prevent diabetes-related complications, including coma, blindness, kidney failure, amputation, impotence and heart disease.
The system is made up of two components, a real-time CGM system and a MiniMed Paradigm insulin pump. The real-time CGM system relays glucose readings every five minutes from a glucose sensor to the insulin pump, which displays to 288 readings a day – nearly 100 times more information than three daily fingersticks.